Email updates

Keep up to date with the latest news and content from BMC Musculoskeletal Disorders and BioMed Central.

Open Access Highly Accessed Study protocol

Use of platelet rich plasma to treat plantar fasciitis: design of a multi centre randomized controlled trial

Joost C Peerbooms1, Wilbert van Laar2, Frank Faber2, Hans M Schuller3, Henk van der Hoeven4 and Taco Gosens5*

Author Affiliations

1 Department of Orthopaedics, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands

2 Department of Orthopaedics, HAGA Ziekenhuis Den Haag, The Netherlands

3 Department of Orthopaedics, Diaconessenhuis Leiden, The Netherlands

4 Department of Orthopaedics, St. Antonius Ziekenhuis Nieuwegein, The Netherlands

5 Department of Orthopaedics, Elisabeth Ziekenhuis Tilburg, The Netherlands

For all author emails, please log on.

BMC Musculoskeletal Disorders 2010, 11:69  doi:10.1186/1471-2474-11-69

Published: 14 April 2010

Abstract

Background

If conservative treatment for chronic plantar fasciitis fails, often a corticosteroid injection is given. Corticosteroid injection gives temporarily pain reduction, but no healing. Blood platelets initiate the natural healing rate. GPS® gives an eightfold concentrate platelets of patients own blood. Injection of these platelets in the attachment of the fascia to the os calcis might induce a healing rate.

Methods and design

A randomized controlled multi centre trial will be performed. The study population consists of 120 patients of 18 years and older. Patients with chronic plantar fasciitis will be allocated randomly to have a steroid injection or an autologous platelet concentrate injections. Data will be collected before the procedure, 4,8,12,26 weeks and 1 year after the procedure.

The main outcome measures of this study are pain and function measured with questionnaires.

Conclusion

Recent literature show positive effects for the treatment of tendinosis with autologous platelet injections. The forthcoming trial will compare treatment for chronic plantar fasciitis with a steroid injection versus an autologous platelet injection. Our results will be published as soon as they become available.

Trial Registration

Trial registration number: http://www.clinicaltrials.gov webcite NCT00758641.